RECENT NEWS
Eli Lilly comes for knockoff weight loss drugs in new ad campaign
Eli Lilly's big investment, cheaper Zepbound, and what's next for Hims & Hers: Pharma news roundup
Hims & Hers can't sell off-brand Ozempic forever. But it can still sell these weight loss drugs
The Nasdaq plunges more than 1% as chip restrictions loom with Nvidia earnings up next